MEMIC Reaches out to Injured Workers Affected by Maine's New Opioid Law

PORTLAND, Maine, December 30, 2016 – Workers' compensation specialist The MEMIC Group is notifying injured workers in Maine taking certain medications that they should contact their prescribing physician as they may be affected by Maine’s new opioid law, LD 1646, which becomes effective on January 1, 2017.

Prescribing physicians may recommend treatment alternatives for those who will be required to lower or limit prescription dosages. Many of the elements around prescription drug monitoring in the new law align with MEMIC’s current best practices. More information on the new law can be found on the websites of the Maine Legislature or Maine Medical Association.


The MEMIC Group includes MEMIC Indemnity Company, MEMIC Casualty Company, and parent company Maine Employers’ Mutual Insurance Company; all rated “A” (Excellent) by A.M. Best. As a super-regional workers’ compensation specialty insurer, The MEMIC Group holds licenses to write workers’ compensation across the country. The group insures more than 20,000 employers and their estimated 300,000 employees, and holds more than $1.2 billion in assets. The group maintains offices in Manchester, NH; Glastonbury, CT; Albany, NY; Weehawken, NJ; West Conshohocken, PA; Tysons Corner, VA; and Tampa, FL; in addition to its headquarters in Portland, ME.